Streetbeat News

Price Targets

CRSP

Needham analyst Gil Blum maintains a Buy rating on CRISPR Therapeutics (NASDAQ:CRSP) but lowers the price target from $88 to $85.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:40 pm

GFL

TD Cowen analyst James Schumm has initiated coverage on GFL Environmental (NYSE:GFL) with an Outperform rating and a price target of $40.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:37 pm

GRNT

B of A Securities analyst John Abbott has initiated coverage on Granite Ridge Resources (NYSE:GRNT) with a Buy rating and a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:36 pm

HD

RBC Capital analyst Steven Shemesh has initiated coverage on Home Depot (NYSE:HD) with a Sector Perform rating and a price target of $303.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:34 pm

LOW

RBC Capital analyst Steven Shemesh has initiated coverage on Lowe's Companies (NYSE:LOW) with a Sector Perform rating and a price target of $194.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:31 pm

BBIO

Citigroup analyst David Lebowitz has initiated coverage on BridgeBio Pharma (NASDAQ:BBIO) with a Buy rating and a price target of $42.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:30 pm

RHI

UBS analyst Kevin Mcveigh has initiated coverage on Robert Half (NYSE:RHI) with a Sell rating and a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:26 pm

ASGN

UBS analyst Kevin Mcveigh has initiated coverage on ASGN (NYSE:ASGN) with a Sell rating and a price target of $72.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:22 pm

ZNTL

Stifel analyst Bradley Canino has maintained a 'Buy' rating on Zentalis Pharma (NASDAQ:ZNTL), but lowered the price target from $44 to $36.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:16 pm

VRTX

Stifel analyst Paul Matteis maintains a 'Hold' rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and raises the price target from $340 to $373.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:14 pm